Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Transplantation. 2022 Dec 8;107(1):254–263. doi: 10.1097/TP.0000000000004265

Table 4.

Mixed-effects multivariable logistic regression model of risk factors for CRE BSI

Baseline characteristic aOR 95% CI P
Prior exposure to a third-generation cephalosporina 2.21 1.17-4.17   0.015
Prior exposure to a carbapenema 2.80 1.54-5.10   0.001
Prior CRE colonization/infectionb 9.86 4.88-19.93 <0.001
Time from transplantation to EB BSI (per d) 0.99 0.99-1.00   0.051
Chronic immunosuppression with mycophenolatec 0.47 0.25-0.89   0.021
Organ transplant type
 Kidney  Ref
 Liver 2.64 1.23-5.65   0.012
 Heart 2.69 0.80-9.02   0.108
 Lung 3.76 1.40-10.09   0.009
 Pancreas 0.68 0.08-6.57   0.740
a

Exposure within the 6 mo before the EB BSI.

b

CRE organism isolated on any microbiological culture from any anatomical site in the 12 months before the EB BSI. No surveillance cultures were performed at the included study sites.

c

Immunosuppression assessed at the time of the EB BSI.

aOR, adjusted odds ratio; BSI, bloodstream infection; CI, confidence interval; CRE, carbapenem-resistant Enterobacterales; EB, Enterobacterales; ref, reference.